LAG3 and HIV-1 infection: A study reported that genome editing of CXCR4 and CCR5 using CRISPR-Cas9 prevented HIV-1 infection in CD4+ T cells by affecting the inhibitory receptors of T cells, like PD-1 and Lymphocyte Activation Gene-3 (LAG3) (Huang et al., 2017).